10- https://doi.org/10.1111/j.1872-034x.2010.00655.x
Chapter 2: Diagnosis and surveillance
Translate Article 
Chapter 2: Diagnosis and surveillance
- Research Article
- 32
- 10.1016/j.jhep.2004.11.014
- Nov 23, 2004
- Journal of Hepatology
Management of patients with hepatitis B virus-induced cirrhosis
- Front Matter
- 5
- 10.1053/j.gastro.2008.11.023
- Nov 28, 2008
- Gastroenterology
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
- Research Article
- 2
- 10.1111/j.1872-034x.2010.00654.x
- May 19, 2010
- Hepatology Research
Chapter 1: Prevention
- Research Article
- 151
- 10.1053/j.gastro.2021.01.233
- Mar 9, 2021
- Gastroenterology
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
- Research Article
- 64
- 10.1016/j.cgh.2006.06.007
- Aug 2, 2006
- Clinical Gastroenterology and Hepatology
Impact of Surveillance on Survival of Patients With Initial Hepatocellular Carcinoma: A Study From Japan
- Discussion
- 15
- 10.1016/s0140-6736(12)61283-5
- Aug 1, 2012
- The Lancet
Hepatocellular carcinoma
- Research Article
- 7
- 10.1053/j.gastro.2022.03.024
- Mar 23, 2022
- Gastroenterology
DETECT: Development of Technologies for Early HCC Detection
- Research Article
- 76
- 10.1016/j.jceh.2014.04.003
- May 22, 2014
- Journal of Clinical and Experimental Hepatology
Hepatocellular carcinoma (HCC) is one of the major causes of morbidity, mortality and healthcare expenditure in patients with chronic liver disease. There are no consensus guidelines on diagnosis and management of HCC in India. The Indian National Association for Study of the Liver (INASL) set up a Task-Force on HCC in 2011, with a mandate to develop consensus guidelines for diagnosis and management of HCC, relevant to disease patterns and clinical practices in India. The Task-Force first identified various contentious issues on various aspects of HCC and these issues were allotted to individual members of the Task-Force who reviewed them in detail. The Task-Force used the Oxford Center for Evidence Based Medicine-Levels of Evidence of 2009 for developing an evidence-based approach. A 2-day round table discussion was held on 9th and 10th February, 2013 at Puri, Odisha, to discuss, debate, and finalize the consensus statements. The members of the Task-Force reviewed and discussed the existing literature at this meeting and formulated the INASL consensus statements for each of the issues. We present here the INASL consensus guidelines (The Puri Recommendations) on prevention, diagnosis and management of HCC in India.
- Research Article
- 446
- 10.1053/j.gastro.2019.02.049
- Apr 12, 2019
- Gastroenterology
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
- Front Matter
- 93
- 10.1053/j.gastro.2009.05.014
- May 29, 2009
- Gastroenterology
α-Fetoprotein for Hepatocellular Carcinoma Diagnosis: The Demise of a Brilliant Star
- Research Article
- 39
- 10.1016/j.cgh.2011.06.004
- Jun 13, 2011
- Clinical Gastroenterology and Hepatology
Surveillance for Hepatocellular Carcinoma in Patients With Cirrhosis
- Front Matter
- 5448
- 10.1016/j.jhep.2011.12.001
- Mar 15, 2012
- Journal of Hepatology
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- Discussion
- 1
- 10.1016/j.cgh.2011.08.003
- Aug 11, 2011
- Clinical Gastroenterology and Hepatology
Hepatocellular Carcinoma: Still in Search of Evidence-Based Care
- Discussion
- 10.1053/j.gastro.2019.02.024
- Feb 19, 2019
- Gastroenterology
Reply
- Research Article
- 78
- 10.1053/j.gastro.2004.09.027
- Nov 1, 2004
- Gastroenterology
Computed tomographic imaging of hepatocellular carcinoma
Save Important notes in documents
Highlight text to save as a note, or write notes directly
You can also access these Documents in Paperpal, our AI writing tool
Powered by our AI Writing Assistant
